Buscar resultados de ensayos clínicos
Cicatrix - 51 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Gene Expression During Surgical Scar Remodeling by Fractional Photothermolysis Condición: Hypertrophic Scars Fecha: 2013-05-16 Intervenciones: Device: Fraxel Repair - Fractional Laser treatment An FDA-approved Fractional 10,600 nm laser source wil |
Recruiting |
Nombre del estudio: To Study Gene Expression of Postburn Hypertrophic Scar Condición: Cicatrix, Hypertrophic Fecha: 2012-08-28 |
Completed |
Nombre del estudio: Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10) Condición:
Fecha: 2009-09-24 Intervenciones:
|
Completed |
Nombre del estudio: Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites Condición:
Fecha: 2009-09-24 Intervenciones:
|
Completed |
Nombre del estudio: Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times Condición:
Fecha: 2009-09-24 Intervenciones:
|
Completed |
Nombre del estudio: To Study Gene Expression of Postburn Hypertrophic Scar Condición: Cicatrix, Hypertrophic Fecha: 2012-08-28 |
Completed |
Nombre del estudio: Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery Condición: Hypertrophic Scars Fecha: 2015-04-11 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Revised Hypertrophic Scars Condición: Hypertrophic Scar Fecha: 2014-09-16 Intervenciones: Drug: RXI-109 |
Not yet recruiting |
Nombre del estudio: A Randomized Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Subjects With Hypertrophic Scar Condición: Hypertrophic Scar Fecha: 2016-10-31 Intervenciones:
|
Withdrawn |
Nombre del estudio: Intron A for the Treatment of Hypertrophic Scar Condición:
Fecha: 2008-05-26 Intervenciones: Drug: interferon alpha 2b 1 million IU of interferon alpha 2b (Intron A) subcutaneously once a day for 7 |